{
    "clinical_study": {
        "@rank": "129310", 
        "arm_group": [
            {
                "arm_group_label": "soy nuts", 
                "arm_group_type": "Experimental", 
                "description": "25 g of soy nuts provided daily to the subjects and they were counseled to replace 25 g of protein in their therapeutic lifestyle change (TLC) diet with the soy.  TLC diet consisted of 30% of energy from total fat (<7% saturated fat, 12% monounsaturated fat and 11% polyunsaturated fat), 15% from protein and 55% from carbohydrate; less than 200 mg of cholesterol per day and 1200 mg of calcium and 2 fatty fish meals per week.  Those ingesting suboptimal dietary calcium were given calcium carbonate supplementation."
            }, 
            {
                "arm_group_label": "Therapeutic lifestyle change diet", 
                "arm_group_type": "Other", 
                "description": "Counseling on therapeutic lifestyle change diet consisting of 30% of energy from total fat (<7% saturated fat, 12% monounsaturated fat and 11% polyunsaturated fat), 15% from protein and 55% from carbohydrate; less than 200 mg of cholesterol per day and 1200 mg of calcium and 2 fatty fish meals per week.  Those ingesting suboptimal dietary calcium were given calcium carbonate supplementation."
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid\n      levels, inflammation and menopausal symptoms in postmenopausal women."
        }, 
        "brief_title": "Soy Nuts and Cardiovascular Risk in Postmenopausal Women", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Postmenopausal Women", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "detailed_description": {
            "textblock": "The present study examines the effect of a whole soy food, soy nuts (dry roasted soybeans),\n      added to the Therapeutic Lifestyle Change diet on blood pressure, lipids, inflammation and\n      menopausal symptoms in postmenopausal hypertensive and normotensive women in a randomized\n      crossover trial during an 8-week period.  We sought to determine whether dietary soy had an\n      additional benefit to the currently recommended heart healthy diet."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women with absence of menses for at least 12 months or irregular periods and hot\n             flashes.\n\n        Exclusion Criteria:\n\n          -  were current cigarette smoking or smoking in the previous year;\n\n          -  clinical coronary artery disease, peripheral artery disease, or cerebrovascular\n             disease;\n\n          -  known diabetes mellitus or a fasting glucose level of 126 mg/dL or greater;\n\n          -  a history of breast cancer; a fasting triglyceride level greater than 400 mg/dL;\n             systolic BP of 165 mm Hg or greater or diastolic BP of 100 mm Hg or greater;\n\n          -  untreated hypothyroidism; systemic or endocrine disease known to affect lipid,\n             mineral, or bone metabolism;\n\n          -  and consumption of more than 21 alcoholic drinks per week.\n\n          -  Use of lipid-lowering drugs, hormone therapy, medications for osteoporosis, and soy\n             products was discontinued for 2 months before entering the study. Participants took a\n             multivitamin but no additional vitamin or mineral supplements or other soy products\n             during the study."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740076", 
            "org_study_id": "2001P-001604"
        }, 
        "intervention": {
            "arm_group_label": [
                "soy nuts", 
                "Therapeutic lifestyle change diet"
            ], 
            "intervention_name": "soy nuts", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes", 
        "lastchanged_date": "December 3, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02215"
                }, 
                "name": "Beth Israel Deaconess Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Soy Nuts on Blood Pressure, Lipids and Inflammation in Postmenopausal Women", 
        "overall_official": {
            "affiliation": "Beth Israel Deaconess Medical Center", 
            "last_name": "Francine Welty, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "stratified by hypertensive status (normal BP, prehypertension, hypertension)", 
            "measure": "Blood pressure", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740076"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "stratified by hypertension status (normotensive or hypertensive)", 
                "measure": "lipid levels", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "stratified by hypertensive status (normotensive or hypertensive)", 
                "measure": "inflammatory markers", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "menopausal symptoms", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Beth Israel Deaconess Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beth Israel Deaconess Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}